Adherence to therapy is defined as the extent to which a person's behavior in taking
medication, following a diet, and/or executing lifestyle changes, corresponds with agreed …

Metformin is the first-line drug treatment for type 2 diabetes. Globally, over 100 million
patients are prescribed this drug annually. Metformin was discovered before the era of target …

Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …

ESC Guidelines 3039 administrative staff and by the referees and supervisory committees of
the two organizations. It is our hope that this huge effort has generated guidelines that will …

OBJECTIVE To determine time to treatment intensification in people with type 2 diabetes
treated with one, two, or three oral antidiabetes drugs (OADs) and associated levels of …

Objectives To provide a systematic and quantitative summary of the association between
severe hypoglycaemia and risk of cardiovascular disease in people with type 2 diabetes and …

Aims/hypothesis The aim of this work was to evaluate the efficacy and safety of canagliflozin
vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with …

OBJECTIVE To investigate the efficacy and tolerability of empagliflozin as add-on to
metformin and sulfonylurea in patients with type 2 diabetes. RESEARCH DESIGN AND …

Background Patients with type 2 diabetes mellitus (T2D) have an increased risk of
cardiovascular disease and mortality compared to the background population …

Introduction: Additional oral antidiabetic agents to metformin, sulfonylureas (SU) and
thiazolidinediones (TZD) are approved for the treatment of type 2 diabetes. Areas covered …